Published note
Switching cost kills momentum before product fit
Migration anxiety can overpower a strong product case long before buyers say so directly. In the current 334-company cohort, 56 of 334 companies made it the main blocker, while 254 of 334 showed at least one public signal for it.
This note isolates one public clue. Use the blocker page for the larger pattern.
Note type
Supporting proof
This page keeps one sharp public observation legible without pretending to replace the company-specific brief.
Related blockers
1
The note stays smaller than the canonical blocker pages it supports.
Public-safe boundary
Private layer stays private
Notes can publish the observation, but not the exact company diagnosis, contacts, or correction path.
Migration anxiety can overpower a strong product case long before buyers say so directly. In the current 334-company cohort, 56 of 334 companies made it the main blocker, while 254 of 334 showed at least one public signal for it.
Observation
- 254 of 334 companies showed at least one public signal for this blocker.
- The upside can look clear while the replacement path still feels too risky.
- 251 of 254 paired it with decision drift, which is why the public note stops at diagnosis instead of publishing the full next move.
First check
Ask what the smallest believable migration step is that would reduce exposure fastest.
Risk if this is misread
If this is misread, teams often keep selling upside while replacement anxiety quietly kills momentum.
What the brief adds
The brief tells one company whether migration anxiety is the real blocker, what sequence should come first, and what not to force all at once. The brief keeps the migration choke points, replacement sequencing, and de-risking order private.
Closing
If the replacement path still feels expensive and exposed, the product may never get the clean comparison it deserves. The brief keeps the migration choke points, replacement sequencing, and de-risking order private.